RecruitingNot ApplicableNCT04716140

Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery

Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions


Sponsor

Tom Lootens

Enrollment

99 participants

Start Date

Sep 15, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to investigate the point or nonsense of treating cartilage lesions at the level of the first metatarsophalane joint. To date, no clear guidelines have been found in the literature with regard to the treatment of cartilage lesions at the MTP I joint during corrective surgery for hallux valgus, nor has it been investigated whether this can have an effect on the clinical outcome.


Eligibility

Min Age: 30 YearsMax Age: 60 Years

Inclusion Criteria1

  • hallux valgus

Exclusion Criteria2

  • younger than 30 years, older than 60 years
  • extra pathologies other than hallux valgus

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDebridement of the MTP1 cartillage lesion and microfracture

Patients with a MTP1 cartillage lesion \> grade I (based on based on the ICRS scale and an MS HoloLens measurement) randomised in the treatment group will be treated with debridement and microfracture


Locations(1)

AZ Maria Middelares

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04716140


Related Trials